Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study

Condition:   Major Depressive Disorder Interventions:   Drug: Escitalopram;   Drug: Brexpiprazole Sponsors:   University Health Network, Toronto;   St. Michael's Hospital, Toronto;   Baycrest;   Centre for Addiction and Mental Health;   McMaster University;   Queen's University;   University of Ottawa;   University of British Columbia;   University of Calgary;   McGill Univ ersity;   Dalhousie University;   University of Michigan;   Simon Fraser University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials